Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - CHANGE IN WORKING CAPITAL
Change in Working Capital HALO - Halozyme Therapeutics, Inc.
-38.7 M
LAST VALUE
-236.83%
2 YEAR CAGR
-45.82%
5 YEAR CAGR
-10.64%
10 YEAR CAGR